Life Expectancy

• 

  Subject Areas on Research

  • "Death and taxes": a contrary view. 
  • A cost-effective analysis of postoperative goal-directed therapy for high-risk surgical patients: improved outcomes are not enough … you have to "show me the money". 
  • A multigene prognostic assay for selection of adjuvant chemotherapy in patients with T3, stage II colon cancer: impact on quality-adjusted life expectancy and costs. 
  • A new method for correcting under-estimation of disabled life expectancy and an application to the Chinese oldest-old. 
  • A reevaluation of the duration of survival after the onset of dementia. 
  • Access to healthcare services makes a difference in healthy longevity among older Chinese adults. 
  • Active Surveillance Versus Nephron-Sparing Surgery for a Bosniak IIF or III Renal Cyst: A Cost-Effectiveness Analysis. 
  • Active life expectancy estimates for the U.S. elderly population: a multidimensional continuous-mixture model of functional change applied to completed cohorts, 1982-1996. 
  • Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. 
  • Adequate access to healthcare and added life expectancy among older adults in China. 
  • Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making. 
  • Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. 
  • Age-specific mortality trends in France and Italy since 1900: period and cohort effects. 
  • Aging and cancer. 
  • An estimation of the global volume of surgery: a modelling strategy based on available data. 
  • Are China's oldest-old living longer with less disability? A longitudinal modeling analysis of birth cohorts born 10 years apart. 
  • Assessing the causal effect of organ transplantation on the distribution of residual lifetime. 
  • Assessing the clinical and economic burden of coronary artery disease: 1986-1998. 
  • Association of Leukocyte Telomere Length With Mortality Among Adult Participants in 3 Longitudinal Studies. 
  • Association of retirement age with mortality: a population-based longitudinal study among older adults in the USA. 
  • Benefits and Harms of Breast Cancer Screening: A Systematic Review. 
  • Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. 
  • Breast cancer in older patients. 
  • CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials. 
  • CVD mortality, 1968-1978: observations and implications. 
  • Can screening older patients for cancer save lives? 
  • Cancer and the functional status of the elderly. 
  • Changes in the age dependence of mortality and disability: cohort and other determinants. 
  • Changing concepts of morbidity and mortality in the elderly population. 
  • Changing health status and health expectancies among older adults in China: gender differences from 1992 to 2002. 
  • Child Development in Low- and Middle-Income Countries. 
  • Childhood psychopathology can be really bad for your health. 
  • Childrearing discipline and violence in developing countries. 
  • Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis. 
  • Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. 
  • Cognitively Intact and Happy Life Expectancy in the United States. 
  • Cohort changes in active life expectancy in the U.S. elderly population: experience from the 1982-2004 National Long-Term Care Survey. 
  • Comparison of temporal changes in U.S. and Swedish lung cancer, 1950-51 to 1981-82. 
  • Compression of mortality: myth or reality? 
  • Computed tomography and radiation risks: what pediatric health care providers should know. 
  • Concerns underlying treatment preferences of advanced cancer patients with children. 
  • Cost effectiveness of a short-term pediatric neurosurgical brigade to Guatemala. 
  • Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. 
  • Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. 
  • Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. 
  • Cost-effectiveness of oral bisphosphonates for osteoporosis at different ages and levels of life expectancy. 
  • Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. 
  • Cost-effectiveness of revascularization strategies: the ASCERT study. 
  • Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. 
  • Cost-effectiveness of treatment of early stage endometrial cancer. 
  • Cross-sectional estimates of active life expectancy for the U.S. elderly and oldest-old populations. 
  • Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. 
  • De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam. 
  • Decreased cancer-independent life expectancy in the head and neck cancer population. 
  • Defining low-value PSA testing in a large retrospective cohort: Finding common ground between discordant guidelines. 
  • Delays in cancer care for children in low-income and middle-income countries: development of a composite vulnerability index. 
  • Demographic and Socioeconomic Disparities in Life Expectancy With Hearing Impairment in the United States. 
  • Demographic challenges for socioeconomic planning. 
  • Demographic trends for the aging female population. 
  • Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. 
  • Distribution of survival times in a real-world cohort of older adults with chronic kidney disease: the median may not be the message. 
  • Divergent trends in life expectancy across the rural-urban gradient and association with specific racial proportions in the contiguous USA 2000-2005. 
  • Do obese persons comprehend their personal health risks? 
  • Does Medical Expansion Improve Population Health? 
  • Dynamic paradigms for human mortality and aging. 
  • Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164. 
  • Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States. 
  • Education-specific estimates of life expectancy and age-specific disability in the U.S. elderly population: 1982 to 1991. 
  • Educational status and active life expectancy among older blacks and whites. 
  • Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. 
  • Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology. 
  • Endothelial progenitor cell therapy for atherosclerosis: the philosopher's stone for an aging population? 
  • Estimates of U.S. multiple cause life tables. 
  • Estimating increment-decrement life tables with multiple covariates from panel data: the case of active life expectancy. 
  • Expected value information improves financial risk taking across the adult life span. 
  • Exposure to Family Member Incarceration and Adult Well-being in the United States. 
  • Forecasting chronic disease risks in developing countries. 
  • Forecasts of active life expectancy: policy and fiscal implications. 
  • From theory to practice: translating research into health outcomes. 
  • Future trends in chronic disability and institutionalization: implications for long-term care needs. 
  • Gender, educational and ethnic differences in active life expectancy among older Singaporeans. 
  • Genetic nature of individual frailty: comparison of two approaches. 
  • Geriatric health: need to make it an essential element of primary health care. 
  • Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. 
  • Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. 
  • Global operating theatre distribution and pulse oximetry supply: an estimation from reported data. 
  • Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. 
  • Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. 
  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. 
  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. 
  • Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. 
  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. 
  • Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. 
  • Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. 
  • Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. 
  • Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. 
  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. 
  • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Health consequences of familial longevity influence among the Chinese elderly. 
  • Health decline, aging and mortality: how are they related? 
  • Health differentials between blacks and whites: recent trends in mortality and morbidity. 
  • Health-based population forecasting: effects of smoking on mortality and fertility. 
  • Heating stress patterns in Caenorhabditis elegans longevity and survivorship. 
  • Heterogeneity in the Strehler-Mildvan general theory of mortality and aging. 
  • High social status males experience accelerated epigenetic aging in wild baboons. 
  • Hip Fractures in Older Adults in 2019. 
  • Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries. 
  • Improving the Validity of Stated-Preference Data in Health Research: The Potential of the Time-to-Think Approach. 
  • Individual aging and mortality rate: how are they related? 
  • Individual and aggregate years-of-life-lost associated with overweight and obesity. 
  • International justice and health: a proposal. 
  • Introduction to decision making over the life span. 
  • Is the use of t-PA as compared with streptokinase cost effective? 
  • Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society. 
  • Learning from Taiwan: experience with universal health insurance. 
  • Left handedness. 
  • Life Expectancy of Adult Survivors of Childhood Cancer Over 3 Decades. 
  • Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. 
  • Life expectancy benefits of cancer screening in the end-stage renal disease population. 
  • Life table techniques for multiple-cause mortality. 
  • Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. 
  • Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. 
  • Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. 
  • Mass incarceration, public health, and widening inequality in the USA. 
  • Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. 
  • Mexico's path towards the Sustainable Development Goal for health: an assessment of the feasibility of reducing premature mortality by 40% by 2030. 
  • Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis. 
  • Morbidity, disability, and long-term care of the elderly: implications for insurance financing. 
  • Mortality model based on delays in progression of chronic diseases: alternative to cause elimination model. 
  • Mortality of the chronically impaired. 
  • Mortality patterns in developed countries. 
  • Mortality recovery and stabilization in Kazakhstan, 1995-2001. 
  • NCCN clinical practice guidelines in oncology: prostate cancer. 
  • National Hospital Quality Rankings: Improving the Value of Information in Hospital Rating Systems. 
  • Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults. 
  • Nonparametric inference on median residual life function. 
  • On the need for a life-span approach to health campaign evaluation. 
  • Overview of women's health. 
  • Palliative care. 
  • Past and future life expectancy increases at later ages: their implications for the linkage of chronic morbidity, disability, and mortality. 
  • Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness. 
  • Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. 
  • Personalized predictive modeling for patients with Alzheimer's disease using an extension of Sullivan's life table model. 
  • Pharmacological considerations in human immunodeficiency virus-infected adults in the intensive care unit. 
  • Population ageing and deaths attributable to ambient PM_2·5 pollution: a global analysis of economic cost. 
  • Population and prehistory III: food-dependent demography in variable environments. 
  • Population impact of mortality reduction: the effects of elimination of major causes of death on the 'saved' population. 
  • Postmenopausal hormone replacement therapy. Information for effective patient counseling. 
  • Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. 
  • Predicting the 30-year risk of cardiovascular disease: the framingham heart study. 
  • Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa. 
  • Putting the Acute Coronary Syndrome in Context After 80 Years of Age. 
  • Quality, quantity, or both? Life after lung transplantation. 
  • Quantification of biological aging in young adults. 
  • Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. 
  • Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. 
  • Recent changes in the U.S. age at death distribution: further observations. 
  • Recent declines in chronic disability in the elderly U.S. population: risk factors and future dynamics. 
  • Rectangularization of the survival curve: implications of an ill-posed question. 
  • Regional differences in the impact of diabetes on population health in the USA. 
  • Regression on quantile residual life. 
  • Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer. 
  • Religious commitment and health status. 
  • Religious involvement and mortality: a meta-analytic review. 
  • Repeated resuscitation: how lifesaving alters life tables. 
  • Reproduction and survival in Mediterranean fruit flies: a "protein and energy" free radical model of aging. 
  • Risk factor dynamics, mortality and life expectancy differences between eastern and western Finland: the Finnish Cohorts of the Seven Countries Study. 
  • Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. 
  • Screening mammography use in older women according to health status: a systematic review and meta-analysis. 
  • Senior adult oncology clinical practice guidelines in oncology. 
  • Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . 
  • Serious Fall Injury History and Adverse Health Outcomes After Initiating Hemodialysis Among Older U.S. Adults. 
  • Sex Difference and Interaction of SIRT1 and FOXO3 Candidate Longevity Genes on Life Expectancy: A 10-Year Prospective Longitudinal Cohort Study. 
  • Should the presence of carcinogens in breast milk discourage breast feeding? 
  • Social/health maintenance organization and fee-for-service health outcomes over time. 
  • Supporting statements and rationale. 
  • Surgery for colorectal cancer in elderly patients: a systematic review. Colorectal Cancer Collaborative Group. 
  • Surveillance issues in inflammatory bowel disease: ulcerative colitis. 
  • Survival after age 80. 
  • Survival after the age of 80 in the United States, Sweden, France, England, and Japan. 
  • Survival differences among native-born and foreign-born older adults in the United States. 
  • Systemic therapy for older women with breast cancer. 
  • Targeting lifesaving: demographic linkages between population structure and life expectancy. 
  • Telomeres and the natural lifespan limit in humans. 
  • The Effect of altering ADL thresholds on active life expectancy estimates for older persons. 
  • The Global Burden of Cancer 2013. 
  • The Impact of Cost Conversations on the Patient-Physician Relationship. 
  • The association between intelligence and lifespan is mostly genetic. 
  • The association of childhood socioeconomic conditions with healthy longevity at the oldest-old ages in China. 
  • The challenge of health care delivery to the elderly patient with cardiovascular disease. Demographic, epidemiologic, fiscal, and health policy implications. 
  • The dynamics of population aging: demography and policy analysis. 
  • The effect of heavy drinking on social security old-age and survivors insurance contributions and benefits. 
  • The effect of metastatic site and decade of diagnosis on the individual burden of metastatic melanoma: contemporary estimates of average years of life lost. 
  • The effectiveness of ovarian cancer screening. A decision analysis model. 
  • The emergence of longevous populations. 
  • The global burden of falls: global, regional and national estimates of morbidity and mortality from the Global Burden of Disease Study 2017. 
  • The global impact of noncommunicable diseases: estimates and projections. 
  • The impact of heterogeneity in individual frailty on the dynamics of mortality. 
  • The influence of Yaa on anti-DNA responses of B6-lpr mice. 
  • The linkage of health status changes and disability. 
  • The long lives of primates and the 'invariant rate of ageing' hypothesis. 
  • The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder. 
  • The propagation of uncertainty in human mortality processes operating in stochastic environments. 
  • The quadratic hazard model for analyzing longitudinal data on aging, health, and the life span. 
  • The return on investment in health care: from 1980 to 2000. 
  • The role of the exercise test in the evaluation of patients for ischemic heart disease. 
  • The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. 
  • The use of life expectancy in cancer screening guidelines. Moving with caution from model-based evidence to evidence-based guidelines. 
  • There is substantial agreement among interspecies estimates of DNA repair activity. 
  • Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort. 
  • Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. 
  • Tokuhashi score is predictive of survival in a cohort of patients undergoing surgery for renal cell carcinoma spinal metastases. 
  • Toward a broader view of values in cost-effectiveness analysis of health. 
  • Towards a more comprehensive understanding of cancer burden in North Carolina: priorities for intervention. 
  • Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies. 
  • Trade-offs in the effects of the apolipoprotein E polymorphism on risks of diseases of the heart, cancer, and neurodegenerative disorders: insights on mechanisms from the Long Life Family Study. 
  • Trends in the health of the aged. 
  • Truth in the most optimistic way. 
  • Using renal transplantation to evaluate a simple approach for predicting the impact of end-stage renal disease therapies on patient survival: observed/expected life span. 
  • What does a fly's individual fecundity pattern look like? The dynamics of resource allocation in reproduction and ageing. 
  • Why gerontologists should care about empirical research on religion and health: transdisciplinary perspectives. 
  • Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009. 
  • Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010. 
  • [Effect of epitalon and melatonin on life span and spontaneous carcinogenesis in senescence accelerated mice (SAM)]. 
  • [Variation of mortality risk among cancer patients and individualized therapy]. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology